Karen Ruckman

  • Associate Professor, Strategy
  • Ph.D. (University of British Columbia); M.A. (Queen's); B.Sc., Honours (University of Alberta)

    Burnaby Room: WMC 4313
    Burnaby Phone: 778.782.5374

    Email Address: ruckman@sfu.ca

    Curriculum Vitae: View

    Biography

    Karen Ruckman, an Associate Professor in Strategy, joined the Beedie School of Business in 2004 from Concordia University in Montreal where she was an Assistant Professor in the John Molson School of Business. Her specialization is firm-level strategic activities with a special focus on technology transfer, licensing and imitation. Her industry focus includes biotechnology and pharmaceuticals, information systems and financial goods.  

    Research Interests

    Technology management, R&D strategy, imitation strategy, acquisition motivation, biotechnology, software, licensing in the biotech sector, business level strategy in the Indian IT sector.

    Selected Publications

    Articles and Reports

    Ruckman, K. E., & McCarthy, I. P. (2017). Licensing speed: Its determinants and payoffs. Journal of Engineering and Technology Management, 46, 52-66. http://doi.org/10.1016/j.jengtecman.2017.11.002

    Ruckman, K. E., & McCarthy, I. P. (2017). Why do some patents get licensed while others do not? Industrial and Corporate Change, 26(4), 667-688. http://doi.org/10.1093/icc/dtw046

    Ruckman, K. E., Saraf, N., & Sambamurthy, V. (2015). Market positioning by IT Service Vendors through imitation. Information Systems Research, 26(1), 100-126. http://doi.org/10.1287/isre.2014.0555

    Ruckman, K. E. (2009). Technology sourcing acquisitions: What they mean for innovation potential. Journal of Strategy and Management, 2(1), 56-75. http://doi.org/10.1108/17554250910948703

    Ruckman, K. E. (2008). Externally sourcing research through acquisition: Should it supplement or substitute for internal research? Industry and Innovation, 15(6), 627-645.

    Ruckman, K. E. (2005). Technology sourcing through acquisitions: Evidence from the U.S. Drug industry. Journal of International Business Studies, 36(1), 89-103.

    Ruckman, K. E. (2005). Technology sourcing through acquisitions: Evidence from the U.S. drug industry. Journal of International Business Studies, 36(1), 89-103.

    Ruckman, K. E. (2004). Entry mode into a foreign market: The case of U.S. Mutual funds in Canada. Journal of International Economics, 62(2), 417-432.

    Ruckman, K. E. (2003). Expense ratios of North American mutual funds. Canadian Journal of Economics, 36(1), 192-223.

    Teaching Related Material

    Ruckman, K. E. (2007). Acquiring biopharmaceutical research: Is market approval a deal breaker? In Cooper, C. L., & Finkelstein, S. (Eds.), Advances in Mergers and Acquisitions Volume 6 (pp. 171-187). Oxford, United Kingdom: Elsevier Ltd (UK).

    Powered by TRACS